DaVita Inc. (DVA) Key Metrics

NYSE: DVAValuation, returns, debt and efficiency ratios over 10 years.

DVA valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$11.95B
Enterprise value
$24.40B
P/E (TTM)
15.8
10-yr median 14.2
Forward P/E
10.0
PEG ratio
0.45
Price / sales
0.9
10-yr median 1.0
Price / book
21.6
10-yr median 3.4
EV / EBITDA
8.8
10-yr median 8.9
Dividend yield
—
Beta
0.80

DVA key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

DVA valuation Price multiples at each fiscal year-end price.

P/E ratio−3.8%
13.4
2025 · hover or tap a bar for each year
2016: 15.0 (−73.2%)2017: 20.8 (+39.3%)2018: 55.6 (+167.1%)2019: 14.2 (−74.4%)2020: 18.6 (+30.8%)2021: 12.8 (−31.3%)2022: 12.8 (−0.1%)2023: 14.1 (+10.5%)2024: 13.9 (−1.3%)2025: 13.4 (−3.8%)
20162025
Price / sales−28.0%
0.7
2025 · hover or tap a bar for each year
2016: 0.9 (−18.4%)2017: 1.3 (+42.5%)2018: 0.8 (−38.8%)2019: 1.0 (+30.3%)2020: 1.2 (+23.0%)2021: 1.1 (−13.6%)2022: 0.6 (−42.7%)2023: 0.8 (+30.5%)2024: 1.0 (+26.7%)2025: 0.7 (−28.0%)
20162025
Price / book+38.4%
8.6
2025 · hover or tap a bar for each year
2016: 2.3 (−10.9%)2017: 2.3 (+3.8%)2018: 1.8 (−24.8%)2019: 3.3 (+87.1%)2020: 5.0 (+50.7%)2021: 5.3 (+6.2%)2022: 3.2 (−39.0%)2023: 3.6 (+10.6%)2024: 6.2 (+75.4%)2025: 8.6 (+38.4%)
20162025
EV / EBITDA−6.1%
8.4
2025 · hover or tap a bar for each year
2016: 7.6 (−40.6%)2017: 8.7 (+13.6%)2018: 8.8 (+1.1%)2019: 9.7 (+11.0%)2020: 11.4 (+16.8%)2021: 9.7 (−15.0%)2022: 9.1 (−6.1%)2023: 8.8 (−2.7%)2024: 8.9 (+0.9%)2025: 8.4 (−6.1%)
20162025
Price / free cash flow−14.2%
7.6
2025 · hover or tap a bar for each year
2016: 11.6 (−34.7%)2017: 13.8 (+19.0%)2018: 11.3 (−18.0%)2019: 8.8 (−21.8%)2020: 11.0 (+24.9%)2021: 9.7 (−12.1%)2022: 7.4 (−23.2%)2023: 6.5 (−12.1%)2024: 8.9 (+35.9%)2025: 7.6 (−14.2%)
20162025
Free cash flow yield+1.9 pts
13.1%
2025 · hover or tap a bar for each year
2016: 8.6% (+3.0 pts)2017: 7.2% (−1.4 pts)2018: 8.8% (+1.6 pts)2019: 11.3% (+2.5 pts)2020: 9.1% (−2.3 pts)2021: 10.3% (+1.2 pts)2022: 13.4% (+3.1 pts)2023: 15.3% (+1.8 pts)2024: 11.2% (−4.0 pts)2025: 13.1% (+1.9 pts)
20162025

DVA valuation history

Fiscal year-endToday10-year median

DVA returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

DVA debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

DVA cash returned to shareholders

DividendsBuybacksFree cash flow

DVA price vs earnings per share

Share price at year-endEPS (right axis)

DVA key metrics

2016–2025
DaVita Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$10.01B$13.05B$9.76B$7.16B$12.51B$14.40B$11.54B$8.87B$13.82B$13.15B
Enterprise value$22.10B$24.27B$20.49B$18.66B$24.00B$25.61B$21.95B$18.65B$22.61B$21.04B
P/E ratio13.413.914.112.812.818.614.255.620.815.0
Price / sales0.71.00.80.61.11.21.00.81.30.9
Price / book8.66.23.63.25.35.03.31.82.32.3
Price / free cash flow7.68.96.57.49.711.08.811.313.811.6
Price / operating cash flow5.36.54.74.66.57.35.65.07.26.7
EV / sales1.61.91.71.62.12.21.91.62.11.4
EV / EBITDA8.48.98.89.19.711.49.78.88.77.6
EV / free cash flow16.916.613.719.418.619.616.823.822.618.6
Earnings yield7.5%7.2%7.1%7.8%7.8%5.4%7.0%1.8%4.8%6.7%
Free cash flow yield13.1%11.2%15.3%13.4%10.3%9.1%11.3%8.8%7.2%8.6%
Dividend yield———3.7%2.0%1.8%0.1%2.2%1.5%1.5%
Shareholder yield (dividends + buybacks)17.9%10.6%2.8%15.0%14.7%11.9%20.8%15.3%7.3%9.8%
Share price at fiscal year-end$113.61$149.55$104.76$74.67$113.76$117.40$75.03$51.46$72.25$64.20
Per share
Revenue per share$154.86$146.84$130.28$121.15$105.68$94.20$74.04$66.17$56.84$71.96
Earnings per share$8.48$10.73$7.42$5.85$8.90$6.31$5.27$0.92$3.47$4.29
Operating cash flow per share$21.41$23.17$22.10$16.33$17.56$16.14$13.47$10.28$9.97$9.58
Free cash flow per share$14.88$16.80$16.00$10.03$11.73$10.64$8.49$4.55$5.24$5.54
Cash per share$8.88$9.69$4.20$3.36$4.40$2.81$7.24$1.89$2.88$5.97
Book value per share$13.15$23.96$29.44$23.22$21.56$23.62$22.75$29.20$30.82$28.42
Tangible book value per share−$75.01−$62.81−$49.07−$52.53−$44.14−$34.16−$22.26−$11.18−$4.32−$24.95
Dividends per share———$2.80$2.22$2.06$0.07$1.14$1.11$0.94
Capex per share$6.54$6.36$6.10$6.30$5.83$5.50$4.98$5.73$4.73$4.05
Debt per share$146.13$138.26$119.30$123.36$108.92$94.30$74.90$58.61$48.79$44.47
Shares outstanding88.1M87.3M93.2M95.8M109.9M122.6M153.8M172.4M191.3M204.9M
Change in shares outstanding+0.9%−6.3%−2.8%−12.8%−10.3%−20.3%−10.8%−9.9%−6.6%−5.2%
Returns & profitability
Return on equity (ROE)46.0%38.7%27.8%24.4%37.1%24.2%19.0%2.9%11.3%14.9%
Return on invested capital (ROIC)11.8%12.8%9.6%7.7%10.3%9.2%8.8%7.8%9.8%10.5%
Return on assets (ROA)4.3%5.5%4.1%3.3%5.7%4.5%4.5%0.8%3.5%4.7%
Return on tangible assets7.7%9.6%7.2%5.8%9.9%7.8%7.8%1.3%5.4%11.3%
Free cash flow margin9.6%11.4%12.3%8.3%11.1%11.3%11.5%6.9%9.2%7.7%
Income quality (OCF / net income)2.532.162.982.791.972.562.5611.112.872.23
Financial health
Total debt$12.87B$12.07B$11.12B$11.82B$11.98B$11.56B$11.52B$10.10B$9.34B$9.11B
Cash & short-term investments$782.0M$846.0M$391.7M$321.8M$484.2M$345.1M$1.11B$326.0M$551.8M$1.22B
Net debt$12.09B$11.22B$10.72B$11.50B$11.49B$11.22B$10.41B$9.78B$8.78B$7.89B
Debt / equity11.115.774.055.315.053.993.292.011.581.56
Debt / assets0.740.700.660.700.700.680.670.530.490.49
Net debt / EBITDA4.584.124.625.594.634.984.624.603.372.86
Current ratio1.291.261.191.201.321.271.561.722.881.48
Quick ratio1.241.211.131.161.281.231.511.702.821.41
Interest coverage3.74.44.03.86.35.63.73.14.24.9
Working capital$916.4M$772.7M$495.7M$535.5M$769.2M$672.6M$1.32B$3.53B$5.70B$1.28B
Invested capital$13.25B$13.31B$13.47B$13.73B$13.86B$14.12B$13.91B$14.81B$14.68B$13.71B
Tangible asset value−$6.61B−$5.48B−$4.57B−$5.03B−$4.85B−$4.19B−$3.42B−$1.93B−$826.7M−$5.11B
Net current asset value−$12.26B−$11.45B−$11.01B−$11.55B−$11.58B−$10.94B−$10.12B−$5.65B−$4.31B−$8.94B
Graham number$50.08$76.06$70.11$55.27$65.71$57.91$51.95$24.65$49.04$52.40
Graham net-net per share−$150.28−$141.89−$127.44−$129.54−$112.82−$96.73−$71.00−$69.04−$56.47−$47.96
Capital allocation
Dividends paid———$267.9M$244.0M$253.1M$11.4M$196.4M$211.5M$192.4M
Share buybacks (net)$1.79B$1.39B$272.2M$802.2M$1.60B$1.46B$2.38B$1.16B$802.9M$1.10B
Dividend payout ratio———47.8%24.9%32.7%1.4%123.2%31.9%21.9%
Dividends + buybacks / free cash flow136.8%94.5%18.3%111.3%142.9%131.3%183.4%173.1%101.2%113.7%
Capex / revenue4.2%4.3%4.7%5.2%5.5%5.8%6.7%8.7%8.3%5.6%
Capex / operating cash flow30.5%27.5%27.6%38.6%33.2%34.1%37.0%55.7%47.5%42.2%
Capex / depreciation0.810.770.760.820.941.071.251.671.161.15
Stock-based compensation / revenue1.0%0.8%0.9%0.8%0.9%0.8%0.6%0.6%0.3%0.3%
SG&A / revenue12.3%12.0%12.1%11.7%10.3%10.8%9.7%10.0%9.8%10.8%
Efficiency
Days sales outstanding73.470.474.778.076.275.075.472.675.856.7
Days of inventory on hand5.45.95.54.85.04.84.76.48.38.6
Days payables outstanding22.822.521.819.619.119.120.021.724.625.2
Cash conversion cycle (days)56.153.858.463.262.060.660.157.359.540.0
Receivables turnover4.975.184.894.684.794.874.845.034.816.44
Payables turnover16.0216.2016.7318.6219.0719.0618.2516.8614.8114.47
Inventory turnover67.4761.9365.9775.8272.7976.2477.0956.6844.0842.41
Asset turnover0.780.750.720.680.680.670.630.600.580.79
Average receivables$2.74B$2.47B$2.48B$2.48B$2.42B$2.37B$2.35B$2.27B$2.26B$2.29B
Average payables$621.7M$530.9M$497.2M$440.9M$418.2M$419.0M$433.6M$486.2M$515.8M$513.7M
Average inventory$147.6M$138.8M$126.1M$108.3M$109.5M$104.8M$102.7M$144.6M$173.3M$175.2M
Intangibles / total assets44.4%43.8%43.3%42.9%42.2%41.7%40.0%36.4%35.5%58.3%

Computed from DVA's annual financial statements (latest annual report filed February 11, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

DVA valuation and financial ratios

At the end of fiscal 2025 (December 31, 2025), DaVita traded at 13.4 times earnings, against a 10-year median of 14.2. Based on the latest twelve months, the trailing P/E is 15.8 and the forward P/E is 10.0. DaVita earned a return on equity of 46.0% and a return on invested capital of 11.8% in fiscal 2025. It ended the year with $12.9 billion of debt and $782.0 million in cash and short-term investments, net debt of $12.1 billion. It returned $1.8 billion to shareholders: $0 in dividends and $1.8 billion in share buybacks, 137% of free cash flow. The share count fell 57.0% from 204.9M to 88.1M over 9 years.

See the DVA income statement, the DVA chart for price history, or the DVA stock overview for the latest quote and news.

DVA key metrics FAQ

What is DaVita's P/E ratio?

DaVita's trailing P/E ratio is 15.8 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 10.0. At the end of fiscal 2025 it was 13.4, compared with a 10-year median of 14.2.

What is DaVita's EV/EBITDA?

DaVita's enterprise value was 8.4 times EBITDA at the end of fiscal 2025 (enterprise value $22.1 billion, EBITDA $2.6 billion); the current EV/EBITDA is 8.8.

What is DaVita's return on equity?

DaVita's return on equity (ROE) was 46.0% in fiscal 2025: net income of $746.8 million on average shareholders' equity of $1.6 billion.

What is DaVita's ROIC?

DaVita's return on invested capital was 11.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does DaVita have?

DaVita had total debt of $12.9 billion at the end of fiscal 2025, a debt-to-equity ratio of 11.11 and $12.1 billion of net debt (4.58 times EBITDA).

Does DaVita buy back its shares?

Yes. DaVita spent $1.8 billion on net share repurchases in fiscal 2025 Shares outstanding changed +0.9% over the year, to 88.1M..

What is DaVita's free cash flow yield?

DaVita generated $1.3 billion of free cash flow in fiscal 2025, a free cash flow yield of 13.1% on its market value at year-end ($10.0 billion).

What is DaVita's current ratio?

DaVita's current ratio was 1.29 at the end of fiscal 2025: current assets were 1.29 times current liabilities.

Medical Care Facilities key metrics